Effect of Age on Antibody Diversity
Effect of Age on Antibody Diversity
批准号:
10250897
负责人:
PATRICIA J GEARHART
金额:
$11.83万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectAgeAnti-CD40AntibodiesAntibody DiversityAntibody FormationAtherosclerosisB-Lymphocyte SubsetsB-LymphocytesC57BL/6 MouseCardiovascular DiseasesCell divisionCell physiologyCellsDiseaseFlow CytometryGoalsIgG1Immunoglobulin Class SwitchingInterleukin-4InterventionLifeLinkLipopolysaccharidesMeasuresMessenger RNAMolecularMusRoleSeverity of illnessSurface ImmunoglobulinsSystemTestingactivation-induced cytidine deaminaseadaptive immune responseage effectantigen bindingimmunological interventionmouse modelnovel
中文摘要
为了确定老年B细胞是否具有与年轻细胞相同的转换同种型的能力,我们纯化了来自C57BL/6小鼠的脾滤泡、边缘区和年龄相关的B细胞亚群。用白细胞介素4和脂多糖或抗cd40刺激细胞,用表面免疫球蛋白流式细胞术检测细胞向IgG1的转换。结果表明,老年小鼠的滤泡和边缘区B细胞的转换是稳健的,与年轻小鼠相当。然而,来自老年小鼠的与年龄相关的B细胞相对于其他亚群切换较差。激活诱导的脱氨酶,启动开关,通过mRNA的qPCR定量表达,在年轻和老年滤泡B细胞中表达相等。因此,在这个离体系统中,来自年轻和年老小鼠的滤泡和边缘带细胞表现相似,表明在老年B细胞中进行转换的分子机制是完整的。
英文摘要
To determine whether old B cells have the same capacity to switch isotypes as young cells, we purified splenic follicular, marginal zone, and age-associated B cell subsets from C57BL/6 mice. Cells were stimulated in culture with interleukin 4 and either lipopolysaccharide or anti-CD40, and switching to IgG1 was measured by flow cytometry of surface immunoglobulin. The results show that switching was robust in follicular and marginal zone B cells from old mice and was comparable to their young counterparts. However, age-associated B cells from old mice switched poorly relative to the other subsets. Expression of activation-induced deaminase, which initiates switching, was quantified by qPCR of mRNA, and it was equal between young and old follicular B cells. Thus, in this ex vivo system, the follicular and marginal zone cells from young and old mice behaved similarly, showing that the molecular machinery to perform switching is intact in old B cells.
The adaptive immune response has been linked to cardiovascular disease, suggesting that potential immune intervention strategies could reduce disease severity and prolong life. To achieve this goal, we have focused on understanding the role of B cells in atherosclerosis. We are testing the role of antibody isotype using a novel mouse model, and we are characterizing the antibodies produced by mouse aortic B cells. We are also determining what antigens they bind and how antibodies can promote disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENERATION OF ANTIBODY DIVERSITY
-
批准号:3301928
-
项目类别:
-
资助金额:$28.11万
-
财政年份:1989
-
负责人:PATRICIA J GEARHART
-
依托单位:
GENERATION OF ANTIBODY DIVERSITY
-
批准号:3301931
-
项目类别:
-
资助金额:$29.66万
-
财政年份:1989
-
负责人:PATRICIA J GEARHART
-
依托单位:
GENERATION OF ANTIBODY DIVERSITY
-
批准号:2181754
-
项目类别:
-
资助金额:$29.47万
-
财政年份:1989
-
负责人:PATRICIA J GEARHART
-
依托单位:
REARRANGEMENT OF VK GENES DURING ONTOGENY
-
批准号:3301930
-
项目类别:
-
资助金额:$17.13万
-
财政年份:1989
-
负责人:PATRICIA J GEARHART
-
依托单位:
REARRANGEMENT OF VK GENES DURING ONTOGENY
-
批准号:3301932
-
项目类别:
-
资助金额:$10.63万
-
财政年份:1989
-
负责人:PATRICIA J GEARHART
-
依托单位:
REARRANGEMENT OF VK GENES DURING ONTOGENY
-
批准号:3301929
-
项目类别:
-
资助金额:$13.68万
-
财政年份:1989
-
负责人:PATRICIA J GEARHART
-
依托单位:
GENERATION OF ANTIBODY DIVERSITY
-
批准号:2181755
-
项目类别:
-
资助金额:$31.9万
-
财政年份:1989
-
负责人:PATRICIA J GEARHART
-
依托单位:
ANTIBODY VARIABLE GENES: DEVELOPMENT AND DIVERSITY
-
批准号:3171882
-
项目类别:
-
资助金额:$12.68万
-
财政年份:1982
-
负责人:PATRICIA J GEARHART
-
依托单位:
ANTIBODY VARIABLE GENES: DEVELOPMENT AND DIVERSITY
-
批准号:3171881
-
项目类别:
-
资助金额:$13.67万
-
财政年份:1982
-
负责人:PATRICIA J GEARHART
-
依托单位:
DNA Repair And Somatic Mutation In Antibody Variable Genes
-
批准号:7592044
-
项目类别:
-
资助金额:$76.89万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
Protein Interactions in Antibody Diversity
-
批准号:8552453
-
项目类别:
-
资助金额:$53.9万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
Protein Interactions in Antibody Diversity
-
批准号:7732301
-
项目类别:
-
资助金额:$20.51万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
DNA REPAIR AND SOMATIC MUTATION IN ANTIBODY VARIABLE GENES
-
批准号:6097872
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
DNA Deamination in Antibody Diversity
-
批准号:8552446
-
项目类别:
-
资助金额:$17.02万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
Protein Interactions in Antibody Diversity
-
批准号:9549348
-
项目类别:
-
资助金额:$129.5万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
Roles for Transcription in Antibody Diversity
-
批准号:8335900
-
项目类别:
-
资助金额:$57.5万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
Effect of Age on Antibody Diversity
-
批准号:8552476
-
项目类别:
-
资助金额:$45.39万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
Effect of Age on Antibody Diversity
-
批准号:8931596
-
项目类别:
-
资助金额:$102.41万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
Protein Interactions in Antibody Diversity
-
批准号:9147332
-
项目类别:
-
资助金额:$130.38万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
DNA Deamination in Antibody Diversity
-
批准号:7732295
-
项目类别:
-
资助金额:$22.02万
-
财政年份:--
-
负责人:PATRICIA J GEARHART
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: